Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 20 is a protein encoded by the TBC1D20 gene and functions as a GTPase-activating protein (GAP) that regulates Rab GTPases, notably Rab1, Rab2, and Rab18[1][3][6][7]. By stimulating GTP hydrolysis, it inactivates these Rab proteins, which are crucial for vesicle trafficking, endoplasmic reticulum morphology, autophagy, and intracellular protein/lipid handling[1][3][5][7]. Mutations in the TBC1D20 gene disrupt normal cell trafficking and are associated with disorders such as Warburg micro syndrome, characterized by neurological and ocular defects[1][4][5]. There are currently no known therapeutic drugs directly targeting TBC1D20, but its role in intracellular transport processes and disease may make it of future pharmacological interest[1][3][4][5].
GTPase-activating protein activity (inactivation of Rab1 and Rab2 GTPases, inactivation of Rab18 for vesicle trafficking and ER function)[1][3][4][6][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 20 (TBC1D20).